Ledger.Open graph →
SEC Form D · Amendment · filed December 22, 2022

ABK Biomedical Inc

Offering
$28.5M
Sold
$28.5M
Exemption
Rule 506(b)
Industry
Other
Location
HALIFAX, Nova Scotia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Carissa B. Black · Halifax, Nova Scotia, CanadaDirectorAravind Arepally · Halifax, Nova Scotia, CanadaExecMike Tyson · Halifax, Nova Scotia, CanadaExecGary Donofrio · Halifax, Nova Scotia, CanadaExecMichael Mangano · Halifax, Nova Scotia, CanadaExec · DirectorKetan Patel · Halifax, Nova Scotia, CanadaDirectorAnthony Headley · Halifax, Nova Scotia, CanadaExecAaron Berez · Halifax, Nova Scotia, CanadaDirectorJames B. Mclaren · Halifax, Nova Scotia, CanadaDirectorMarc Gregoire · Halifax, Nova Scotia, CanadaExecDan Bonne · Minneapolis, MNDirectorA. John S. Murphy · Boston, MADirectorDavid T. Dart · Lewisville, TXExecSteven T. Grimshaw · Lewisville, TXExecHami T. Ebrahimi · Lewisville, TXExec · DirectorChad Eisenberg · Chicago, ILExecMichael Peck · Chicago, ILDirectorJustin Elliott · Minneapolis, MNDirectorJonathan T. Seiffer · Lewisville, TXExecAndrew Kaufmann · Jacksonville, FLExecDavid Dobrowski · Halifax, Nova Scotia, CanadaExecAnton V. Zavyalov · London, United KingdomExecPavel Mamai · London, United KingdomExecBrooks Norris · For Smith, ARExecScot Melland · Toronto, Ontario, CanadaExec · DirectorThomas Cahill · Miami, FLDirectorJonathan Bull · Co. Dublin, IrelandDirectorAndrew Barr · Berkeley, CAExecCcf GP, LLC · Greenwich, CTExecWesley N. Tang-Wymer · New York, NYDirectorAlbert D. Friedberg · Rochester, NYDirectorDavid Dobrowski · Halifax, Nova Scotia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗